The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study

BACKGROUND: The use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) in patients with type 2 diabetes mellitus (T2DM) remains limited, especially in those with other compelling indications. Thus, this study aimed to describe the prescribi...

Descripción completa

Detalles Bibliográficos
Autores principales: Korayem, Ghazwa B., Alshaya, Omar A., Alghamdi, Albandari A., Alanazi, Shahad S., Almutib, Renad T., Alsaileek, Mahdi, Alrashidi, Abdulrahman, Aldosari, Nasser, Bin Sheraim, Nader, Al Yami, Majed S., Almohammed, Omar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673169/
https://www.ncbi.nlm.nih.gov/pubmed/36408008
http://dx.doi.org/10.3389/fpubh.2022.1031306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673169/
https://www.ncbi.nlm.nih.gov/pubmed/36408008
http://dx.doi.org/10.3389/fpubh.2022.1031306

Ejemplares similares